817 related articles for article (PubMed ID: 31295812)
1. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
4. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
[TBL] [Abstract][Full Text] [Related]
5. Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse.
Nakajima A; Aoyama Y; Nguyen TT; Shin EJ; Kim HC; Yamada S; Nakai T; Nagai T; Yokosuka A; Mimaki Y; Ohizumi Y; Yamada K
Behav Brain Res; 2013 Aug; 250():351-60. PubMed ID: 23714077
[TBL] [Abstract][Full Text] [Related]
6. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
7. 6-demethoxynobiletin, a nobiletin-analog citrus flavonoid, enhances extracellular signal-regulated kinase phosphorylation in PC12D cells.
Kimura J; Nemoto K; Yokosuka A; Mimaki Y; Degawa M; Ohizumi Y
Biol Pharm Bull; 2013; 36(10):1646-9. PubMed ID: 23934345
[TBL] [Abstract][Full Text] [Related]
8. Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies.
Nakajima A; Ohizumi Y; Yamada K
Clin Psychopharmacol Neurosci; 2014 Aug; 12(2):75-82. PubMed ID: 25191498
[TBL] [Abstract][Full Text] [Related]
9. [Preventive action of nobiletin, a constituent of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, against amyloid-beta peptide-induced neurotoxicity expression and memory impairment].
Yamakuni T; Nakajima A; Ohizumi Y
Yakugaku Zasshi; 2010 Apr; 130(4):517-20. PubMed ID: 20371995
[TBL] [Abstract][Full Text] [Related]
10. Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice.
Nakajima A; Yamakuni T; Haraguchi M; Omae N; Song SY; Kato C; Nakagawasai O; Tadano T; Yokosuka A; Mimaki Y; Sashida Y; Ohizumi Y
J Pharmacol Sci; 2007 Sep; 105(1):122-6. PubMed ID: 17895593
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity.
Youn K; Lee S; Jun M
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689949
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
13. Nobiletin Reduces Intracellular and Extracellular β-Amyloid in iPS Cell-Derived Alzheimer's Disease Model Neurons.
Kimura J; Shimizu K; Kajima K; Yokosuka A; Mimaki Y; Oku N; Ohizumi Y
Biol Pharm Bull; 2018; 41(4):451-457. PubMed ID: 29607920
[TBL] [Abstract][Full Text] [Related]
14. Predicting structural features of selected flavonoids responsible for neuroprotection in a Drosophila model of Parkinson's disease.
Maitra U; Conger J; Owens MMM; Ciesla L
Neurotoxicology; 2023 May; 96():1-12. PubMed ID: 36822376
[TBL] [Abstract][Full Text] [Related]
15. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.
Jeong KH; Jeon MT; Kim HD; Jung UJ; Jang MC; Chu JW; Yang SJ; Choi IY; Choi MS; Kim SR
J Med Food; 2015 Apr; 18(4):409-14. PubMed ID: 25325362
[TBL] [Abstract][Full Text] [Related]
16. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
[TBL] [Abstract][Full Text] [Related]
17. 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling.
Telerman A; Ofir R; Kashman Y; Elmann A
BMC Complement Altern Med; 2017 Jun; 17(1):332. PubMed ID: 28645294
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effects of Flavonoids Against Parkinson's Disease.
Jung UJ; Kim SR
J Med Food; 2018 May; 21(5):421-432. PubMed ID: 29412767
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
Frandsen JR; Narayanasamy P
Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
[TBL] [Abstract][Full Text] [Related]
20. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
